Pfizer Is Poised to Shatter These 2 Records in 2022

Pfizer Is Poised to Shatter These 2 Records in 2022

Source: 
Motley Fool
snippet: 
  • Pfizer's Paxlovid appears to be on track to become the best-selling non-vaccine drug ever.
  • Pfizer seems likely to generate the most annual revenue ever for a pharma company.
  • However, 2022 could be Pfizer's peak.